Jeff Yass’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.58M Buy
+38,167
New +$1.54M ﹤0.01% 6839
2026
Q2
– Sell
-5,844
Closed -$201K – 13768
2026
Q1
$201K Buy
+5,844
New +$200K ﹤0.01% 11695
2025
Q1
– Sell
-47,518
Closed -$1.28M – 12808
2024
Q4
$1.28M Buy
47,518
+4,252
+10% +$119K ﹤0.01% 6356
2024
Q3
$1.25M Buy
43,266
+19,188
+80% +$549K ﹤0.01% 6307
2024
Q2
$656K Buy
24,078
+6,162
+34% +$165K ﹤0.01% 7587
2024
Q1
$502K Sell
17,916
-13,712
-43% -$378K ﹤0.01% 8508
2023
Q4
$842K Buy
31,628
+19,444
+160% +$490K ﹤0.01% 7404
2023
Q3
$312K Sell
12,184
-28,917
-70% -$765K ﹤0.01% 9267
2023
Q2
$1.08M Buy
41,101
+474
+1% +$12.5K ﹤0.01% 6510
2023
Q1
$1.06M Buy
40,627
+31,172
+330% +$835K ﹤0.01% 6655
2022
Q4
$259K Buy
+9,455
New +$252K ﹤0.01% 9461
2022
Q3
– Sell
-24,675
Closed -$652K – 13505
2022
Q2
$652K Sell
24,675
-27,373
-53% -$724K ﹤0.01% 7616
2022
Q1
$1.38M Buy
52,048
+24,178
+87% +$624K ﹤0.01% 6339
2021
Q4
$755K Sell
27,870
-28,296
-50% -$743K ﹤0.01% 8039
2021
Q3
$1.44M Buy
56,166
+16,125
+40% +$423K ﹤0.01% 6601
2021
Q2
$1.04M Buy
40,041
+19,814
+98% +$512K ﹤0.01% 7668
2021
Q1
$516K Sell
20,227
-16,051
-44% -$421K ﹤0.01% 9386
2020
Q4
$935K Buy
36,278
+20,424
+129% +$508K ﹤0.01% 6871
2020
Q3
$379K Sell
15,854
-8,929
-36% -$214K ﹤0.01% 8250
2020
Q2
$567K Sell
24,783
-7,522
-23% -$167K ﹤0.01% 7111
2020
Q1
$644K Buy
+32,305
New +$704K ﹤0.01% 6393
2019
Q2
– Sell
-26,559
Closed -$568K – 10411
2019
Q1
$568K Buy
+26,559
New +$552K ﹤0.01% 6029
2017
Q4
– Sell
-56,488
Closed -$1.13M – 9449
2017
Q3
$1.13M Buy
56,488
+33,811
+149% +$682K ﹤0.01% 5058
2017
Q2
$469K Buy
+22,677
New +$457K ﹤0.01% 6761

Other funds holding FTXH

Jeff Yass's FTXH Position: Q3 2026 in Review

Jeff Yass opened a new position in First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q3 2026: 38,167 shares worth $1.58M. The stake represents ﹤0.01% of the portfolio and ranks #6839 among its holdings. This is a return to the name: Jeff Yass previously reported a position in FTXH as recently as Q1 2026.

Jeff Yass first reported a position in FTXH in Q2 2017 and has held it in 24 quarters since. 71 funds tracked by Wall St. Rank hold FTXH as of Q3 2026.

  • Jeff Yass held 38,167 shares of First Trust Nasdaq Pharmaceuticals ETF worth $1.58M as of Q3 2026.
  • First Trust Nasdaq Pharmaceuticals ETF was a new Jeff Yass position in Q3 2026.
  • First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #6839 holding.
  • Jeff Yass first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q2 2017 and has held it in 24 quarters since.
  • 71 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.